Introduction
Ras-related small GTPases act as guanine nucleotide binding switches that regulate a wide variety of cell functions including cell proliferation, dierentiation and apoptosis (Campbell et al., 1998; Reuther and Der, 2000) . Within the Ras subfamily are branches with transforming capability, including those of Ras and R-Ras, and those that are nontransforming, including those of Rap, Ral, and Rheb. Members of these branches of the Ras subfamily are covalently modi®ed by farnesyl or geranylgeranyl isoprenoid lipids that are the ®rst step in targeting to cellular membranes, and both their lipid modi®cation and their correct subcellular localization are required for proper biological function . In addition, such proteins also require modi®cation by palmitic acid acylation for full activity (Hancock et al., 1990) .
Recently, a novel branch of the Ras subfamily has been described, whose members share highly conserved GTP binding motifs but do not contain any known lipidation motifs. Members of this novel branch include Rit (Ras-like protein in tissues), Rin (Ras-like protein in neurons) and the Drosophila protein RIC (Ras-related protein which interacted with calmodulin). Dendrograms of the Ras family show that Rit and Rin form a distinct subfamily more highly related to the Ras and R-Ras branches than to the Rap, Ral or Rheb branches (Campbell et al., 1998) . The conservation of Rit and Rin from¯ies to humans suggests conservation of important physiological functions.
Rit proteins have been cloned independently by groups looking for calmodulin binding proteins (Wes et al., 1996) , retinally expressed Ras-related proteins (Lee et al., 1996) and, fortuitously, retinally expressed farnesylated proteins (Shao et al., 1999) . Unique features of this branch include calmodulin binding for the neuronally expressed forms, lack of prenylation or other lipidation signals in all members, and a distinct but conserved G2 core eector domain (HDPTIEDAY) in which histidine is substituted for tyrosine at position 32, and alanine is substituted for serine at position 39. This level of similarity to other Ras family members suggests that Rit proteins likely possess distinct but partially overlapping functions with other branches of the Ras family. No characterization of their cellular functions has yet been performed.
As an initial step in the biological characterization of Rit and Rin, we investigated their ability to regulate cell growth, transformation, and several signaling pathways used by other Ras family proteins. We found that Rit signaled to Rasresponsive elements and transformed NIH3T3 cells to tumorigenicity, but failed to activate the ERK, JNK, p38 or PI3-K/Akt kinases, indicating that Rit regulates growth control by dierent eector pathways than the other transforming members of the Ras family.
Results
To characterize the potential of Rit and Rin in signaling and transformation activities typical of Ras family members, we generated mammalian expression constructs encoding HA epitope-tagged constitutively activated forms of these proteins. Due to the presence of additional N-terminal sequences, Rit(30V) and Rit(79L) are analogous to the constitutively GTPbound Ras mutants 12V and 61L, respectively, while Rin(78L) is analogous to Ras(61L).
Alone, activated Rit does not form foci of morphologically transformed cells, but does do so in synergistic cooperation with Raf-1 and RhoA By abrogating normal contact inhibition, several transforming members of the Ras family have the ability to form foci of piled-up transformed cells on a background monolayer of untransformed cells. To determine whether Rit and Rin could confer this property on NIH3T3 cells, we transfected pKH3 expression plasmids of constitutively activated Rit or Rin mutants into NIH3T3 cells and observed them for the appearance of foci. Alone, Rit and Rin were not morphologically transforming in a standard NIH3T3 focus formation assay ( Figure 1a ). However, Rit and Rin might trigger some but not all the pathways necessary for focus information. Therefore, to supply potentially missing partner pathways, we also cotransfected Rit and Rin with low levels (200 ng) of activated forms of other eectors, Rho family proteins, or cooperating oncogenes including Raf-1, RalGDS, PI3-K, RhoA, Rac1, CDC42, or Myc. Both Rit(79L) and Rin(78L) cooperated in a synergistic manner with an activated form of Raf-1 [N-terminally truncated Raf(22W)] (Stanton et al., 1989) to form foci of morphologically transformed cells ( Figure 1a ). Rit(79L) but not Rin(78L) also cooperated with activated Rho (Figure 1a ). Neither Rit nor Rin cooperated in this assay with any of the other cotransfected plasmids (data not shown). Rit(30V), although much more weakly than Rit(79L), also cooperated with both Raf and Rho A, but not with any of the other proteins tested (data not shown).
Foci formed by cooperation between Rit and Raf have a Rho-like appearance
In our hands, Ras family oncogenes cooperating with Raf produce foci with a Ras-or Raf-like phenotype (Khosravi-Far et al., 1995; Westwick et al., 1997) . Surprisingly, Rit+Raf foci did not do this, but instead formed foci with a Rac/Rho-like appearance despite the absence of any transfected Rac or Rho in the assay. Like Ras, Raf(22W) alone forms swirling foci or highly refractile cells (Khosravi-Far et al., 1996) (Figure 1b, left panel) . In contrast, RhoA and Rac1 form foci with a dense center of nonrefractile cells in a starburst pattern (Khosravi-Far et al., 1995 , 1996 Qiu et al., 1995a,b) (Figure 1b , right panel). Although Rit(79L) causes no focus formation when transfected alone, when transfected with low levels of an activated form of either Raf(22W) or RhoA(63L), Rit(79L) causes the appearance of foci nearly all of which are Rho/Raclike ( Figure 1b, center panel) . (The occasional appearance of Ras/Raf-like foci is likely to result from foci formed in cells which received Rafexpressing plasmid but not Rit-expressing plasmid.) The appearance of Rit(30V)+Raf and Rin(78L)+ Raf foci is identical to that of Rit(79L)+Raf foci (data not shown). The Rac/Rho like appearance of these foci suggested that Rit and Rin might activate Rho family eectors to cause this characteristic phenotype. However, when microinjected into porcine aortic endothelial cells, neither Rit(79L) nor Rin(78L) produced any morphological alterations such as the stress ®bres typical of Rho activation or the lamellipodia typical of Rac activation, despite very high levels of Rit/Rin protein expression as determined by immunostaining for the HA epitope tag (Marc Symons, personal communication). The results seen in the focus forming assay showed that Rit and Rin could synergize with Raf to abrogate normal contact inhibition in NIH3T3 cells, which is one hallmark of transformation. Other typical transformation phenotypes include altered cellular morphology, growth advantage in monolayer culture, reduced dependence on serum growth factor requirements, acquisition of anchorage independent growth, and tumorigenicity in nude mice. To measure these properties of transformation, we ®rst generated NIH3T3 cells stably expressing each of the Rit and Rin mutants by cotransfecting with empty pZIPneo vector and pooling the resulting (4100) drug-resistant colonies. As shown in Figure 2 , each Rit and Rin protein was detected in its respective stable cell line upon immunoblotting with anti-HA antibody directed against the HA epitope tag. Rit(30V), like the analogous Ras(12V), displays a slightly slower electrophoretic mobility than WT, whereas Rit(79L), like the analogous Ras(61L), displays a faster mobility. Rit(35N), analogous to the dominant negative Ras(17N), was expressed consistently at levels far lower than either its WT or activated counterparts, whether in stable cell lines or transient transfectants. Rin(78L) reproducibly ran as a doublet on our long format, low percentage cross-linker gels; we are investigating the possibility of post-translational modi®cation such as phosphorylation.
As expected from the appearance of the foci seen with Rit+Raf or Rit+Rho, in which contact inhibition was abrogated but the morphology of most of the cells comprising the foci remained normal, the morphology of Rit(79L)-expressing cells also appeared largely normal under optimal conditions of log phase growth (data not shown). Only when cells were grown at high density or under stressed conditions such as low serum, did they begin to become spindly and refractile (Figure 6, upper right panel) . These morphological changes were not correlated with any changes in level of protein expression (data not shown).
Of all the forms of Rit and Rin tested, only Rit(79L) conferred a major proliferative advantage on NIH3T3 cells. The growth curve shown in Figure 3a demonstrates that cells expressing Rit(79L), after an initial Figure 2 Stable expression of Rit, Rin and mutants in NIH3T3 cells. To detect the expression of Rit and Rin, stable transfectants were lysed, and equal amounts of protein were separated by SDS ± PAGE and subjected to Western blotting with anti-HA antibody (BAbCO, mono-HA). It is not clear why Rin(78L) reproducibly runs as a doublet a b c Figure 3 Rit(79L) but not Rin(78L) stable transfectants demonstrate properties of growth transformation. (a) Growth advantage in monolayer culture. Growth curves were generated for NIH3T3 cells stably expressing various mutants of Rit and Rin, or vector or Ras controls, as described in Materials and methods. Cells were counted from duplicate dishes every other day for 2 weeks. (b) Growth in low serum. Stable transfectants were grown in culture medium containing 10, 2 or 0.5% calf serum. Dishes were stained and photographed at 10 days. (c) Anchorage-independent growth. Stable transfectants were seeded into 0.3% soft agar over a 0.6% agar bottom layer. Colonies were photographed at *18 days and variable lag upon plating, grew at a faster rate and reached a higher saturation density than those transfected with empty vector. Neither Rit(WT) nor Rin(78L) conferred a growth advantage, nor did Rit(30V) (data not shown). Indeed, Rin(78L) cells were at a growth disadvantage.
Constitutive expression of Rit(79L) also reduces serum growth factor requirements. As shown in Figure  3b , NIH3T3 cells expressing only empty vector require supplementation with 10% serum, and are unable to grow under conditions of only 2% serum supplementation. In contrast, cells expressing Rit(79L) are able to proliferate in both 2 and 0.5% serum, indicating that this activated mutant triggers pathways leading to reduced dependence on growth factors in serum. Rin(78L) does not reduce growth factor requirements, and cells expressing this mutant form of Rin are unable to grow in 2% serum (Figure 3b ). Similarly, neither Rit(WT)-nor Rit(30V)-expressing cells can grow in 2% serum (data not shown).
A hallmark of transformation is the ability to grow in an anchorage-independent manner. As shown in Figure 3c , Rit(79L) stable transfectants form colonies in soft agar (with a colony forming eciency of approximately 12%), whereas cells stably transfected with Rin(78L) or empty vector do not. Thus, NIH3T3 cells stably expressing Rit(79L) demonstrate many properties of the transformed phenotype in vitro.
To determine whether these transformed properties confer the full malignant phenotype in vivo, Rit(79L) stable transfectants were inoculated subcutaneously into nude mice. Tumors grew at each site injected with these cells (Table 1) , with a latency of approximately 17 days, compared to 10 days for the H-Ras(61L) positive control. In contrast, mice injected with cells expressing Rit(30V), Rit(WT), Rin(78L) or empty vector controls remained tumor-free even after an additional 2 months. Thus, Rit(79L), but not Rin(78L), could confer a tumorigenic phenotype on NIH3T3 cells.
Rit(79L) activates Ras-responsive promoter elements including SRF, NF-kB, Jun and Elk
Rit(79L) displays several aspects of the transformed phenotype, but its core eector domain contains several residues distinct from that of Ras family members. To determine whether the Ras-related proteins Rit and Rin can activate Ras-responsive promoter elements (RREs), we performed transcriptional transactivation reporter assay. NIH3T3 cells were transfected with pKH3 expression plasmids for Rit, Rin, Ras or empty vector, along with reporter plasmids in which luciferase expression is driven by minimal promoters for SRF, NF-kB, Elk-1 or Jun. Rit(79L) consistently activated each of these promoters (Figure 4a ± d), displaying 2 ± 7-fold activation over vector-only controls, depending on the reporter. We consistently saw higher activation of SRF and NF-kB responsive reporters with Rit (5 ± 8-fold) compared to Elk-1 (3 ± 5-fold) or Jun (2 ± 3-fold). Because the pKH3-H-Ras(61L) positive control gave 2 ± 5-fold activation greater than that seen with Rit, but this degree of activity was not as robust an activation as seen when expressed from other vectors (which is typically 10 ± 100-fold activation, depending on the reporter), we speculate that Rit might also promote even stronger transactivation if expressed from a dierent construct.
Rit(79L) fails to activate p38, JNK or ERK MAP kinases, or the PI3-K/Akt pathway Ras proteins signal to the RREs described above by activating several downstream kinases, particularly those leading to the MAPK cascades. We wished to Figure 4 Rit(79L) activates Ras-responsive promoter elements including SRF, NF-kB, Jun and Elk. For transcriptional transactivation reporter assays, NIH3T3 cells were transfected with 100 ng pKH3 expression plasmids for activated Rit, Rin, Ras or empty vector, along with reporter plasmids in which luciferase expression is driven by minimal promoters for SRF, NF-kB, Jun, or Elk-1. After 48 h, cells were starved O/N in 0.5% serum, and the levels of luciferase activity in cell lysates determined using chemiluminescent substrate from Analytical Luminescence. RLU were normalized to the levels of activity seen with vector controls, and the results are reported as fold activation over vector alone 
NIH3T3 cells transiently (foci) or stably (all others) transfected with pKH3-Rit or -Rin constructs were analysed for acquisition of various aspects of the transformed phenotype as described in Materials and methods determine whether Rit signaling to these RREs also utilized activation of the same MAPK cascades. In addition, Ras also activates the PI3-K/Akt pathway, which is upstream of NF-kB and c-Jun, both of which were stimulated by Rit in reporter assays. Oli, 1999) . We treated Rit-and Ras-transformed cells grown on plastic with the FTIs FTI-277 (Lerner et al., 1995) and L-744,832 (Kohl et al., 1995) both in normal culture conditions and in low serum conditions. Under conditions of culture in complete growth medium (10% serum), FTI treatment did not result in death either in transformed or in normal vector control cells (data not shown). This was not the case when cells grown in low serum were treated with FTIs. Cells transformed by either Ras or Rit are fully capable of proliferating in 2% serum (Figures 3b and 6 , upper middle and right panels). Unexpectedly, when we treated these transformed cells with FTI-277 under conditions of low serum, both the Ras-transformed and the Rit-transformed cells underwent apoptosis ( Figure 6 , bottom panels on right). Vector control cells, which proliferate well in 10% serum ( Figure 6 , lower left panel), die in 2% serum even in the absence of FTI ( Figure 6 , upper left panel), so we were unable to determine whether FTIs had any additional eects on these cells in low serum conditions. We also tested whether FTImediated apoptosis was a universal feature of cells transformed by Ras family proteins and found that it was not; cells transformed by a mutant form of HRas(61L) that is geranylgeranylated instead of farnesylated are resistant to FTI-mediated apoptosis (data not shown). To assure that the results were not due to a peculiarity of FTI-277, we performed the identical experiment with L-744,832, which is a P-g-ATP and their respective substrates as described in Materials and methods. Following SDS ± PAGE and transfer to Immobilon of each kinase reaction, the amount of radioactivity transferred to each substrate was analysed by phosphorimaging (upper panels). Blots were probed for kinase levels (middle panels) with anti-HA (ERK) or M2 anti-FLAG (JNK, p38 and Akt), and for small GTPases (lower panels) with anti-HA. Thus, although Rit is not itself farnesylated, its ability to promote survival and growth in low serum is dependent on the processing and function of one or more farnesylated proteins.
Discussion
The continued identi®cation of novel Ras-related small GTPases prompts the question of whether newly identi®ed Ras family members have biological activities similar to or dierent from those already characterized. Sequence comparison of Rit and Rin (Lee et al., 1996; Wes et al., 1996) with other members of the Ras superfamily (Campbell et al., 1998) suggests that they are likely to belong to the Ras subfamily but represent a distinct branch of their own, which also includes the Drosophila protein RIC (Wes et al., 1996) . Despite their high degree of conservation in the GTP-binding domains, Rit and Rin possess C-terminal sequences not seen in any other Ras family proteins. Further, their eector domain sequences, although highly related to those of Ras proteins, are distinct at particular conserved residues (Lee et al., 1996; Wes et al., 1996) . Finally, the biological activity of all other members of the Ras family identi®ed requires their modi®cation by either farnesyl or geranylgeranyl isoprenoids , whereas Rit and Rin possess no known lipidation signal. Lipid modi®cation is important for the subcellular localization and protein/protein interactions of all proteins so modi®ed. The fact that neither Rit nor Rin is lipid modi®ed emphasizes the possibility that Rit and Rin protein activities are distinct from any Ras branch recognized previously.
Our comparison of Rit and Rin biological activities to Ras family signaling and transformation con®rms that these proteins display a unique combination of properties. Inspection of their core eector domain sequences shows that Rit and Rin are more similar to the transforming family members of Ras and R-Ras than to Ral, Rap, and Rheb. Consistent with this, the activated Rit mutant (79L) clearly confers on NIH3T3 cells many aspects of the transformed phenotype.
Growth transformation properties displayed by NIH3T3 cells stably expressing Rit(79L) include enhanced proliferation rates and higher saturation density in monolayer culture, proliferation under conditions of growth factor deprivation (2 and 0.5% serum), anchorage-independent growth as shown by soft agar colony formation, and tumorigenicity in nude mice. Each of these properties is shared by all members of the Ras family (H-, and K-Ras) and of the R-Ras family (R-Ras, TC21 and M-Ras) (Bos, 1997; Reuther and Der, 2000) . However, constitutively activated Ras and R-Ras family proteins are also able to form foci of transformed NIH3T3 cells, while Rit(79L) is not. Thus, Rit does not display all the hallmarks of transformation seen with Ras and R-Ras family proteins.
Rit(79L) does form foci synergistically in cooperation with activated forms of Raf [Raf(22W)] and RhoA [RhoA(63L)]. Surprisingly, the appearance of these foci is consistently very Rho/Rac-like, whether Rho is cotransfected or not. Whereas typical foci induced by Ras and Raf are composed of elongated, refractile cells growing in a swirling pattern , Rho/Rac-like foci are mainly contact inhibited, being composed of morphologically normal cells growing in a starburst pattern emanating from a dense core of nonrefractile cells (Khosravi-Far et al., 1995; Qiu et al., 1995a,b) . Although Rit synergized with RhoA in focus formation, and therefore was unlikely to be activating RhoA itself, we wondered whether Rit was triggering Rho family eector pathways to produce such foci. Microinjection of activated forms of Rit and Rin into porcine aortic endothelial cells failed to produce any evidence of cytoskeletal alterations associated with Rho family activity such as stress ®bres or lamellipodia, despite high levels of Rit and Rin proteins visible by immuno¯uorescent staining with antibody to the HA epitope tag (Marc Symons, personal communication). However, since the eectors utilized by Rho proteins for transformation and cytoskeletal alterations are not identical (Qiu et al., 1995b; Sahai et al., 1998; Westwick et al., 1997; Zohar et al., 1998) , it is still possible that Rit uses some of the same eectors as Rho.
Alternatively, it is possible that Rit+Raf foci appear Rho-like merely because the combination of Rit and Raf confers only loss of contact inhibition, without altering individual cellular morphology or cell-cell signals. Ras, TC21 and M-Ras all cause foci with a similar appearance of elongated, highly refractile cells growing in a swirling pattern. In contrast, foci of RRas transformed cells are characteristically of unde®ned shape Saez et al., 1994) , and are quite distinct from the starburst patterns with the dense centers seen with Rho proteins. Raf alone causes foci indistinguishable from Ras foci, so the combination of Raf with Rit must interfere with some of the morphological alterations conferred by Raf. In summary, Rit does not induce the same set of focusforming activities as members of either of the other transforming branches of Ras family proteins.
In contrast to Rit(79L), which displayed strong transforming activity in several dierent functional assays, we were able to detect transforming activity in Rit(30V) only in the focus forming cooperation assay with Raf and Rho. In this assay, although the phenotype was the same as with Rit(79L), the numbers of foci generated were very few, with only 2 or 3 foci seen per dish. Although Ras proteins mutated at positions 12 and 61 do not appear to dier signi®cantly in their transforming activity, this is not true for at least two members of the R-Ras family. In R-Ras and TC21, the GTPase mutant analogous to that at position 61 of Ras (i.e., Rit(79L)) is substantially (up to 10-fold) more transforming than the mutant analogous to that at position 12 of Ras (i.e. Rit(30V)) (Graham et al., 1994; Saez et al., 1994) . The observed dierences in Rit transforming activity are not merely a result of the expression of more Rit(79L), as we observed similar levels of protein expression for Rit(79L) and Rit(30V). Thus, as in the R-Ras family, a`12V' mutation in Rit does not confer the same properties as does a`61L' mutation.
In contrast to the constitutively activated forms of Rit, we were unable to detect any growth consequences as a result of overexpressing the nonmutated form of Rit protein. NIH3T3 cells stably overexpressing Rit(WT) were indistinguishable from those expressing empty vector. Although overexpression of nonmutated Ras proteins can confer on NIH3T3 cells some aspects of transformation, as can overexpression of wild type TC21 (Graham et al., 1994) , the same is not true for RRas . Neither Rit(WT) nor RRas(WT) has any noticeable phenotype in any cell line tested except the latter in an MDCK tubulogenesis model (Khwaja et al., 1998) . We also attempted to determine whether Rit(35N), which is analogous to the dominant negative Ras(17N), had any eect on the proliferation of NIH3T3 cells. Cells are known to require the activity of Ras for progression through G1/ S of the cell cycle (Downward, 1997; Malumbres and Pellicer, 1998; Marshall, 1999) , and Ras(17N) is growth inhibitory (Feig and Cooper, 1988) . The cognate mutant in R-Ras [R-Ras(43N)] has no eect on cell proliferation (Hu et al., 1997) although it alters cellular functions as diverse as dierentiation (Keely et al., 1999) and integrin activation (Zhang et al., 1996) . Unexpectedly, cells expressing Rit(35N) were easily selected by antibiotic resistance and had a reproducible enhancement in their growth rates and saturation densities compared to vector controls in monolayer culture. In this respect they dier from both the Ras and the R-Ras branches. It is not yet clear whether this re¯ects a dierent role for Rit in growth regulation or dierent consequences to Rit activity when Rit is mutated at this residue. Rit(35N) displayed no other evidence of altered growth control.
Finally, in contrast to the very active Rit(79L), the only activity we could detect with constitutively activated Rin(78L) was cooperation with Raf(22W) but not RhoA in the focus forming assay. Unlike Rit(79L), overexpression of Rin(78L) resulted in no growth transformation in any of the assays tested. Indeed, cells expressing Rin(78L) often seemed at a growth disadvantage, with growth curves lower than vector and a consistently¯attened appearance of cells in long term culture. Because Rin (unlike the ubiquitously expressed Rit) is selectively expressed in neural-derived tissues, it is entirely possible that NIH3T3 ®broblasts do not possess the appropriate eectors for correct Rin function.
In an initial eort to characterize the signaling pathways utilized by Rit to produce deregulated growth and transformation, we asked whether Rit (or Rin) could signal to any of the Ras-responsive elements (RREs) activated by members of the Ras and R-Ras branches. In keeping with their stimulation of multiple pathways, Ras family proteins stimulate a wide variety of transcription factors (Campbell et al., 1998; Davis, 1995) . Using transcriptional transactivation reporter assays, we found that Rit(79L) consistently signaled to RREs including SRF, NF-kB and Elk-1, with a lower level of transactivation of the minimal c-Jun promoter. Consistent with their lack of activity in the transformation assays, we observed no transcriptional transactivation with Rit(30V), Rit(WT), or Rin(78L).
Members of the Ras and R-Ras families signal to these RREs to variable extents. Whereas Ras proteins signal strongly to SRF and Elk-1 via the Raf/MEK/ MAPK cascade (Marshall, 1996) , R-Ras family proteins activate Raf poorly or not at all (Graham et al., 1996; Hu et al., 1997; Marte et al., 1997; Osada et al., 1999; Rosario et al., 1999) . Nevertheless, they too can signal to both SRF and Elk-1, although not as well as Ras proteins. R-Ras activates PI3-K strongly but signals to NF-kB transcriptional transactivation more weakly than Ras (Marte et al., 1997; Osada et al., 1999) . The levels of RRE activation seen with Rit are more similar to that seen with R-Ras than with Ras proteins, so we considered the possibility that Rit might also activate gene transcription not via Raf but via PI3-K.
Ras activation of downstream kinases including members of the MAPK cascade and the PI3-K/Akt pathway has been characterized extensively (Campbell et al., 1998; Webb et al., 1998) . We asked whether Rit was signaling to the same RREs as Ras by activating the same downstream kinases. Using transient immune complex kinase assays, we found that neither Rit nor Rin activated ERK, JNK, p38 or Akt signi®cantly. Because Rit did not activate any of these kinases that are commonly activated downstream of Ras, it must use dierent means to produce some of the same properties of growth deregulation as Ras.
While this biological characterization was in progress, we also characterized Rit and Rin biochemically in vitro, and found that they interact with known Ras eectors RalGDs, Rlf and AF-6, but fail to interact in vitro with full length Raf or with the P110 catalytic subunit of PI3-K (Shao et al., 1999) . The latter two results are likely to explain the lack of Rit activation of ERK and PI3-K/Akt kinase activity. However, even though Rit could not activate ERK or PI3-K/Akt, it could transactivate SRF, NF-kB, Elk-1 and (less well) Jun reporters, which lie downstream of these kinases. This seeming paradox may be explained by alternate eector utilization. For example, the RalGDS relative Rlf can signal to AP-1 via Fos (Wolthuis et al., 1997) , as can RGL (Murai et al., 1997; Okazaki et al., 1997) . Rho also transactivates SRF, NF-kB and Elk-1 reporters, although it fails to activate ERK or PI3-K (Sahai et al., 1998; Zohar et al., 1998) .
We are currently screening for novel Rit targets that mediate Rit biological activity. As part of this investigation, we discovered a novel RalGDS family member similar to RGL (RalGDS-like) which, like RalGDS and Rlf, is a potential eector of Rit function (Shao and Andres, 2000) . Thus, it will be important to investigate further the role of RalGDS family members in Rit signaling and transformation.
While the biological signi®cance of their subcellular localization is not known, Myc epitope-tagged Rit and Rin have been shown to localize to the plasma membrane (Lee et al., 1996) . These proteins are thus the only members of the Ras subfamily to localize to the plasma membrane in the absence of any lipid modi®cation. We expected therefore that Rit-transformed cells would be resistant to farnesyltransferase inhibitors (FTIs), which block the lipid modi®cations on Ras proteins Oli, 1999) . We treated cells growing in 2% serum, a level of supplementation sucient for transformed, but not normal, cell survival and growth, with two dierent FTIs. To our surprise, we found that, although Rit itself is not farnesylated, Rit-transformed cells depend for survival in low serum on the function of a farnesylated protein(s). Both Ras-and Rit-transformed cells in low serum underwent apoptosis in the presence of FTIs but not vehicle; in normal culture conditions, neither underwent apoptosis. Recent reports now indicate that FTIs that do not cause apoptosis in cells grown in normal culture conditions can do so when cells are subjected to an additional stressor such as growth factor deprivation (Suzuki et al., 1998) or anchorage deprivation (Lebowitz et al., 1997) . This eect is selective for transformed cells, including both Ras-transformed rodent ®broblasts and human tumor cell lines. Very recent work indicates that a likely candidate for one such survival factor is an as yet unidenti®ed protein that regulates Akt1/2 (Du et al., 1999; Jiang et al., 2000) . There is now also genetic evidence suggesting that RhoB is required for FTImediated apoptosis, as RhoB 7/7 cells are resistant to apoptosis in low serum (Liu et al., 2000) . It is not yet known whether both Ras and Rit require the same downstream farnesylated protein to avoid apoptosis triggered by reduced growth factors, or whether either RhoB or an Akt-regulatory protein is involved in the Ras-and Rit-transformed cell death seen here in the presence of FTIs.
In summary, we demonstrate here that constitutively active Rit but not Rin causes deregulated growth and transforms NIH3T3 cells to tumorigenicity. Rit but not Rin transcriptionally transactivates Ras responsive elements such as SRF, NF-kB, Elk-1 and c-Jun, but not via the usual kinase cascades of Raf/Mek/MAPK, JNK, p38 or PI3-K/Akt. Rit downstream signaling may be accomplished in part via RalGDS family proteins such as RalGDS, Rlf, RGL or a novel RGL protein, and is likely to use entirely novel eectors not yet identi®ed. It will be interesting to delineate the regulators, eectors, physiological stimuli and consequences of Rit activation.
Materials and methods

Plasmids, cells and generation of stable cell lines
Plasmids The cloning of Rit and Rin has been described (Shao et al., 1999) . All Rit and Rin mutants used in these studies were constructed in the mammalian expression vector pKH3 (Mattingly et al., 1994) as BglII fragments inserted in frame with the 36HA epitope tag. Expression from pKH3 is driven by the CMV promoter. The positive control plasmid pKH3-H-ras(61L) was generated from a BamHI fragment taken from pCGN-H-ras(61L) (Fiordalisi et al., 2000) . For kinase assays, cells were cotransfected with epitope-tagged ERK, pCMV-HA-MAPK (gift of Michael Weber); JNK, pFLAG-JNK1; p38, pFLAG-p38a/Mpk2 (both gifts of Michael Karin); or Akt, pFLAG-Akt (TO Chan, to be described elsewhere, construct based on pCMV6-HA-Akt, (Franke et al., 1995) ). For use as kinase assay substrates, recombinant GST-fusion proteins were generated from pGST-c-Jun(1 ± 79) and pGST-ATF2(1 ± 254) (gifts of Michael Karin) (Westwick et al., 1997) .
Cells NIH3T3 cells were grown in Dulbecco's modi®ed Eagle medium (DMEM-high glucose) supplemented with 10% Colorado calf serum (Colorado Serum Company) and penicillin/streptomycin at 378C in a humidi®ed atmosphere of 10% CO 2 . To generate NIH3T3 cell lines stably expressing Rit proteins, cells were cotransfected with pKH3-Rit plasmids (neo s ), along with empty pZIPneo vector (neo r ) (Cepko et al., 1984) , using our standard calcium phosphate method . After 3 days, cells were split into selective medium containing 400 mg/ml active G418 (Geneticin, GIBCO/BRL). After selection, 4100 antibiotic resistant colonies were pooled for further use. To detect the expression of Rit and Rin, stable transfectants were lysed in sample buer, and equal amounts of protein were separated by SDS ± PAGE and subjected to Western blotting as described previously using anti-HA antibody (mono-HA, BAbCO).
Transformation assays
Focus forming activity NIH3T3 cells were transfected with 200 ng to 1 mg each of pKH3 mammalian expression plasmids encoding Rit or Rin, along with 200 ng to 1 mg of empty vector or plasmids encoding Raf(22W) (Stanton et al., 1989; Yen et al., 1994) , RhoA (63L) (Khosravi-Far et al., 1995) , Rac1(115I) (Khosravi-Far et al., 1995) , CDC42(12V) (Chuang et al., 1997) , RalGDS-CAAX (Peterson et al., 1996) or v-Myc (gifts of Channing Der) or the p110 subunit of PI-3K (Kodaki et al., 1994 ) (gift of Julian Downward). In general, higher levels of DNA gave more foci. Foci were counted at 14 ± 21 days. Positive control Ras plasmid gave too many foci to count when transfected at only 50 ng. For photography, cells were ®xed with methanol/acetic acid V : V 1 : 3, and stained with 0.4% crystal violet in methanol/acetic acid as described .
Anchorage-dependent proliferation Growth curves were generated for NIH3T3 cells stably expressing various mutants of Rit and Rin, or vector or Ras controls as described . In brief, stably transfected NIH3T3 cells were seeded at 2610 4 per well in 6 well plates, then trypsinized and counted from duplicate dishes every other day for 2 weeks.
Dependence on serum growth factors Proliferation in culture medium containing normal 10% calf serum was compared to proliferation in 2 or 0.5% calf serum by plating stable transfectants at 2610 4 cells per 60 mm dish. After attachment overnight in complete medium, cells were switched to medium containing either 10, 2 or 0.5% calf serum and fed twice weekly until they were stained with crystal violet and photographed at day 10 after plating.
Anchorage-independent proliferation To determine the ability of Rit and Rin mutants to confer anchorage independent growth, colony formation in soft agar was assessed as described . Stable transfectants were seeded at 10 5 cells per dish in 0.3% bacto-agar (Difco) over a 0.6% agar bottom layer. Colonies were photographed at 14 ± 18 days after seeding.
Tumorigenicity in nude mice NIH3T3 cells stably expressing Rit(30V), Rit(79L), Rin(78L), or empty vector or H-Ras(61L) controls were injected subcutaneously into nude mice (6 week-old female BALB/C nu/nu) at 10 6 cells per site, two sites per mouse as described . Tumors formed within three weeks; mice negative for tumors were observed for an additional 2 months before sacri®ce.
Transient transactivation reporter assays
To determine whether Rit and Rin can activate Rasresponsive promoter elements, NIH3T3 cells were transfected with 100 ng of pKH3 expression plasmids for Rit, Rin, Ras or empty vector, along with reporter plasmids in which luciferase expression is driven by minimal promoters for SRF [1 mg (SREm)2-Luc], NF-kB [1 mg 36NF-kB-Luc], Jun [1 mg Jun-Luc], or Elk [250 ng Gal-Elk-1+2.5 mg 56Gal-Luc] exactly as described previously (Hauser et al., 1995) . After 48 h, cells were starved O/N in 0.5% serum, and the levels of luciferase activity in cell lysates were determined using chemiluminescent substrate from Analytical Luminescence Laboratories (San Diego, CA, USA) according to the manufacturer's instructions. Relative luciferase units (RLU) were normalized to the levels of activity seen with vector controls, and the results are reported as fold activation over vector alone.
In vitro immune complex kinase assays
To assess their ability to signal to the Ras-responsive reporters by activating MAP kinase pathways, activation of p38, JNK and ERK MAP kinases by Rit and Rin was tested in transient immune complex kinase assays as described (Franke et al., 1995; Westwick et al., 1997) . Cos cells were transfected with expression plasmids for Rit, Rin, Ras or empty vector, along with plasmids encoding epitope-tagged MAP kinases. After 48 h, cells were starved overnight in 0.5% serum, and cell lysates were taken. The transfected kinases were immunoprecipitated with antibodies directed against the appropriate epitope tag (HA for ERK (Mono-HA, BAbCo, Berkeley, CA, USA) and FLAG for p38 and JNK (M2, Sigma, St. Louis, MO, USA) and the immunoprecipitates collected on protein A/G agarose beads (Santa Cruz Biotech, Santa Cruz, CA, USA). The collected MAPKs were then subjected to kinase assays as described (Franke et al., 1995; Westwick et al., 1997) to test their ability to transfer [ 32 P-g]ATP to their respective substrates after a 20 min incubation in kinase buer. The substrate for ERK was myelin basic protein (MBP, Sigma); for JNK, GST-cJun(1 ± 79); and for p38, GST-ATF2(1 ± 254). Recombinant GST-Jun and GST-ATF2 fusion proteins were puri®ed from bacterial lysates as described (Westwick et al., 1997) . After separation of the kinase reactions on SDS ± PAGE, proteins were transferred to Immobilon (Millipore), and the level of radioactivity analysed by phosphorimager analysis of the blot. To determine activation of the PI3-K/Akt pathway, experiments were carried out as described for the MAPKs, assessing the ability of transfected FLAG-Akt to phosphorylate a histone H2B substrate (Sigma) (Franke et al., 1995) . To assess the levels of transfected small GTPases and kinases, the blots were probed with anti-HA (Rit, Rin, Ras, ERK) or M2 anti-FLAG (JNK, p38 and Akt) antibodies.
Treatment with FTase inhibitors (FTIs)
Cells stably expressing empty vector, Ras or Rit growing in 2% serum were seeded in six well plates and allowed to attach overnight. The culture medium was then replaced with fresh medium containing 2% serum and either vehicle or one of the FTIs FTI-277 (Lerner et al., 1995) or L-744,832 (Kohl et al., 1995) . FTIs are made up as 10 mM stocks in the appropriate vehicle (DMSO/10 mM DTT or DMSO, respectively) and diluted to a ®nal concentration of 3 ± 10 mM. FTI-277, now available from Calbiochem (San Diego, CA, USA), was a kind gift of SaõÈ d Sebti and Andy Hamilton. L-744,832, now available from Bio-Mol (Plymouth Meeting, PA, USA), was a kind gift of Jay Gibbs and Allen Oli.
